Hiromachi, Japan

Yasunobu Sato

This inventor holds 5 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasunobu Sato. Retrieved from https://idiyas.com/inventor/yasunobu-sato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Tokyo, JA (1976 - 1977)
  • Hiromachi, JP (1982 - 1984)
  • Tokyo, JP (1985)

Company Filing History:


Years Active: 1976-1985

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Yasunobu Sato: Pharmaceutical Patent Inventor

Introduction

Yasunobu Sato is an inventor associated with Hiromachi, Japan, and Sankyo Company, Limited. The supplied information credits him with 5 patents, including inventions concerning quinazoline derivatives and pharmaceutical compositions.

Latest Patents

Two of Sato’s listed patents relate to compounds with potential pharmaceutical applications.

“Acylaminoquinazoline Derivatives and a Pharmaceutical Composition” describes acylaminoquinazoline derivatives with a range of possible substituents, as well as a pharmaceutical composition containing such compounds.

“4-Amino-6,7-dimethoxy-2-piperazinylquinazoline Derivatives” concerns piperazinylquinazoline and homopiperazinylquinazoline compounds with antihypertensive activity. The patent also describes their use in pharmaceutical compositions, with the derivatives serving as the active antihypertensive component.

Career Highlights

Sato’s listed patent work reflects research into medicinal chemistry and pharmaceutical development, particularly quinazoline-based compounds. His association with Sankyo Company, Limited connects his inventive work with a pharmaceutical company.

Collaborations

The supplied information names Hiroyuki Koike and Hiroshi Fukumi as Sato’s coworkers. Their inclusion indicates professional connections in the context of his work, though specific joint contributions are not provided.

Conclusion

Yasunobu Sato’s listed inventions focus on quinazoline derivatives and potential pharmaceutical treatments, including compounds with antihypertensive activity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…